Clinical Trials Browser

UNKNOWN × Interventional × Paclitaxel × Clear all

Esophageal Squamous Cell Carcinoma

NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Phase NA Not yet recruiting

500 enrolled

Breast

Breast Neoplasms

NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2 Completed

41 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

Phase 2/3 Unknown

360 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Phase 2 Unknown

120 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Phase 3 Unknown

200 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03308552 2019-01-02

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Phase 3 Unknown

164 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03328234 2019-01-02

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

Phase 3 Unknown

2 enrolled

Gastrointestinal

IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer

NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

Phase 3 Recruiting

300 enrolled

Gastrointestinal

Esophageal Neoplasms, Recurrence

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Phase 2 Unknown

29 enrolled

Breast

Breast Neoplasms

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Phase 1/2 Unknown

60 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell

NCT02446574 2017-10-24

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Phase 1/2 Completed

33 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02429622 2017-01-18

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

Phase 1/2 Completed

80 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02133612 2015-04-14

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Phase 2 Completed

43 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Phase 2 Unknown

200 enrolled

Breast

Breast Neoplasms

NCT01797900 2014-09-10

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Phase 2 Completed

130 enrolled

Head & Neck

Nasopharyngeal Neoplasms

NCT01444547 2014-05-06

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Phase 2 Unknown

92 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01134523 2013-03-15

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

Phase 3 Unknown

1,000 enrolled

Breast

Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Phase 3 Unknown

100 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01276769 2011-11-16

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Phase 2 Unknown

80 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

Regimens Comparison for Breast Cancers of Positive Lymph Nodes

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer